Loading organizations...
§ Private Profile · Cambridge, MA, USA
Novel anti-cancer therapies reprogramming the tumor microenvironment.
Parthenon Therapeutics has raised $65.0M across 1 funding round.
Parthenon Therapeutics has raised $65.0M in total across 1 funding round.
Parthenon Therapeutics has raised $65.0M across 1 funding round. Most recently, it raised $65.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 3, 2021 | $65M Series A | Northpond Ventures, Taiho Ventures | Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KDT Ventures, Park West Asset Management, Section 32, Tekla Capital Management | Announced |
Parthenon Therapeutics has raised $65.0M in total across 1 funding round.
Parthenon Therapeutics's investors include Northpond Ventures, Taiho Ventures, Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Park West Asset Management, Section 32, Tekla Capital Management.